Zobrazeno 1 - 10 of 22 pro vyhledávání: '"Ivo Minárik"'
1
Cancer detection rates and inter-examiner variability of MRI/TRUS fusion targeted biopsy and systematic transrectal biopsy
Autor: Roman Zachoval, Vanda Adamcová, Miroslav Zalesky, Marek Babjuk, Ivo Minárik, Jiri Stejskal
Publikováno v: Biomedical Papers, Vol 164, Iss 3, Pp 314-319 (2020)
Background: Software-based MRI/TRUS fusion biopsy depends on the coordination of several steps, and inter-examiner differences could influence the results. The aim of this bicentric prospective study was to compare the detection rates of MRI/TRUS fus
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::566c7633ea8f90e594e82b30257ea649
https://doi.org/10.5507/bp.2019.050
Zobrazit plný text záznamu
2
External validation of extended prostate biopsy nomogram
Autor: Tomáš Sieger, Marek Babjuk, Jan Hrbáček, Ivo Minárik
Publikováno v: Central European Journal of Urology
INTRODUCTION: Historical nomograms for the prediction of cancer on prostate biopsy, developed in the sextant biopsy era are no more accurate today. The aim of this study was an independent external validation of a 10-core biopsy nomogram by Chun et a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3015d4987931534a5f01c4cf189d6c39
http://europepmc.org/articles/PMC4526620
Zobrazit plný text záznamu
4
The meaning of sampling density in multiple repeat prostate biopsies
Autor: Michal Kýr, Otakar Čapoun, Roman Sobotka, Tomáš Hanuš, Jan Hrbáček, Marek Babjuk, Ivo Minárik
Publikováno v: Central European Journal of Urology
Introduction Extended transrectal ultrasound-guided prostate biopsy is a state-of-the-art tool for prostate cancer detection. Nevertheless, approximately 1/3 of cancers are missed when using this method and repeat biopsy sessions are often required.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::160cc20a12a3e5ffd9aba03ac2374dbd
https://pubmed.ncbi.nlm.nih.gov/28127449
Zobrazit plný text záznamu
5
Parameters derived from the postoperative decline in ultrasensitive PSA improve the prediction of radical prostatectomy outcome
Autor: S. Vesely, Marek Schmidt, Pavel Dusek, Marko Babjuk, Ivo Minárik, Ladislav Jarolím
Publikováno v: World Journal of Urology. 31:299-304
Contemporary tools estimating increased risk of prostate cancer (PCa) relapse after radical prostatectomy (RP) are far from perfect and there has been an intensive search for additional predictive variables. We aimed to explore whether the parameters
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7982f506275c8a165f1ca87a2caa225c
https://doi.org/10.1007/s00345-012-0892-3
Zobrazit plný text záznamu
8
FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer
Autor: Zdenek Linke, Jana Prausová, Michal Podrazil, Jirina Bartůnková, Jitka Fucikova, Anna Sediva, Vít Budinský, Hana Ulcová, Ivo Minárik, Daniela Rozkova, Radek Spisek, Hana Tiserová, Jan Lastovicka
Publikováno v: Clinical Immunology. 131:1-10
Immunotherapy has emerged as another treatment modality in cancer. The goal of immunotherapy in advanced cancer patients does not have to be the complete eradication of tumor cells but rather the restoration of a dynamic balance between tumor cells a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30a8a2e66ec0728d5af18892ad410689
https://doi.org/10.1016/j.clim.2009.01.001
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje